References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1/2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Balducci, E., Bonucci, A., Picchianti, M., Pogni, R., & Talluri, E. (2011). Structural and functional consequences induced by post-translational modifications in α-Defensins. International Journal of Peptides, 2011, 594723. https://doi.org/https://doi.org/10.1155/2011/594723
- Brogden, K. A. (2005). Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature Reviews. Microbiology, 3(3), 238–250. https://doi.org/https://doi.org/10.1038/nrmicro1098
- Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. https://doi.org/https://doi.org/10.1002/jcc.21287
- Dabirian, S., Taslimi, Y., Zahedifard, F., Gholami, E., Doustdari, F., Motamedirad, M., Khatami, S., Azadmanesh, K., Nylen, S., & Rafati, S. (2013). Human Neutrophil Peptide-1 (HNP-1): A new anti-leishmanial drug candidate. PLoS Neglected Tropical Diseases, 7(10), e2491. https://doi.org/https://doi.org/10.1371/journal.pntd.0002491
- de Leeuw, E., Li, C., Zeng, P., Li, C., Diepeveen-de Buin, M., Lu, W. Y., Breukink, E., & Lu, W. (2010). Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Letters, 584(8), 1543–1548. https://doi.org/https://doi.org/10.1016/j.febslet.2010.03.004
- Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., & Appel, R. D. (2005). Protein identification and analysis tools on the ExPASy Server. In: Walker JM, editor. The Proteomics Protocols Handbook. Humana Press. p. 571–607.
- Guruprasad, K., Reddy, B. V., & Pandit, M. W. (1990). Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Engineering, 4(2), 155–161. https://doi.org/https://doi.org/10.1093/protein/4.2.155
- Im, W., Beglov, D., & Roux, B. (1998). Continuum solvation model: Computation of electrostatic forces from numerical solutions to the Poisson–Boltzmann equation. Computer Physics Communications, 111(1-3), 59–75. https://doi.org/https://doi.org/10.1016/S0010-4655(98)00016-2
- Jo, S., Vargyas, M., Vasko-Szedlar, J., Roux, B., & Im, W. (2008). PBEQ-Solver for online visualization of electrostatic potential of biomolecules. Nucleic Acids Research, 36(Web Server issue), W270–W275. https://doi.org/https://doi.org/10.1093/nar/gkn314
- Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/https://doi.org/10.1021/ci200227u
- Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019). The antimicrobial peptides and their potential clinical applications. American Journal of Translational Research, 11(7), 3919–3931.
- London, N., Raveh, B., Cohen, E., Fathi, G., & Schueler-Furman, O. (2011). Rosetta FlexPepDock web server-high resolution modeling of peptide-protein interactions. Nucleic Acids Research, 39(Web Server issue), W249–W253. https://doi.org/https://doi.org/10.1093/nar/gkr431
- Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., Richardson, J. S., & Richardson, D. C. 3rd,. (2003). Structure validation by Calpha geometry: Phi, psi and Cbeta deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450. https://doi.org/https://doi.org/10.1002/prot.10286
- Lundy, F. T., Nelson, J., Lockhart, D., Greer, B., Harriott, P., & Marley, J. J. (2008). Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. Molecular Immunology, 45(1), 190–193. https://doi.org/https://doi.org/10.1016/j.molimm.2007.04.018
- Mathew, B., & Nagaraj, R. (2017). Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing. PLOS One, 12(4), e0175858 https://doi.org/https://doi.org/10.1371/journal.pone.0175858
- Malin, J. J., & de Leeuw, E. (2019). Therapeutic compounds targeting Lipid II for antibacterial purposes. Infection and Drug Resistance, 12, 2613–2625. https://doi.org/https://doi.org/10.2147/IDR.S215070
- Moazzezy, N., Asadi Karam, M. R., Rafati, S., Bouzari, S., & Oloomi, M. (2020). Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm. PLOS One, 15(7), e0235892 https://doi.org/https://doi.org/10.1371/journal.pone.0235892
- Müller, A., Klöckner, A., & Schneider, T. (2017). Targeting a cell wall biosynthesis hot spot. Natural Product Reports, 34(7), 909–932. https://doi.org/https://doi.org/10.1039/c7np00012j
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
- Rost, B. (1996). PHD: Predicting one-dimensional protein structure by profile-based neural networks. In Methods in Enzymology (vol. 266, pp. 525–539). Academic Press. https://doi.org/https://doi.org/10.1016/S0076-6879(96)66033-9
- Varkey, J., & Nagaraj, R. (2005). Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrobial Agents and Chemotherapy, 49(11), 4561–4566. https://doi.org/https://doi.org/10.1128/AAC.49.11.4561-4566.2005
- Varney, K. M., Bonvin, A. M., Pazgier, M., Malin, J., Yu, W., Ateh, E., Oashi, T., Lu, W., Huang, J., Diepeveen-de Buin, M., Bryant, J., Breukink, E., Mackerell, A. D., Jr,., & de Leeuw, E. P. (2013). Turning defense into offense: Defensin mimetics as novel antibiotics targeting lipid II. PLoS Pathogens, 9(11), e1003732 https://doi.org/https://doi.org/10.1371/journal.ppat.1003732
- Wilde, C. G., Griffith, J. E., Marra, M. N., Snable, J. L., & Scott, R. W. (1989). Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. The Journal of Biological Chemistry, 264(19), 11200–11203.
- Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res, 35(Web Server issue), W407–W410. issue), https://doi.org/https://doi.org/10.1093/nar/gkm290
- Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics (Oxford, England)), 32(23), 3676–3678. https://doi.org/https://doi.org/10.1093/bioinformatics/btw514
- Xu, D., Zhang, J., Roy, A., & Zhang, Y. (2011). Automated protein structure modeling in CASP9 by I‐TASSER pipeline combined with QUARK‐based ab initio folding and FG‐MD‐based structure refinement. Proteins: Structure, Function, and Bioinformatics, 79 (S10), 147–160. https://doi.org/https://doi.org/10.1002/prot.23111
- Xu, D., & Zhang, Y. (2013). Toward optimal fragment generations for ab initio protein structure assembly. Proteins, 81(2), 229–239. https://doi.org/https://doi.org/10.1002/prot.24179